CLCNKB Antibody, Biotin conjugated

說明書

中文名稱：

CLCNKB兔多克隆抗體, Biotin偶聯
貨號：

CSB-PA005488LD01HU
規(guī)格：

￥880
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品名稱：

Rabbit anti-Homo sapiens (Human) CLCNKB Polyclonal antibody
Uniprot No.：

P51801
基因名：

CLCNKB
別名：

Bartter syndrome type 3 antibody; Chloride channel Kb antibody; Chloride channel kidney B antibody; Chloride channel protein ClC-Kb antibody; Chloride channel voltage sensitive Kb antibody; ClC K2 antibody; ClC-K2 antibody; ClCK2 antibody; CLCKB antibody; CLCKB_HUMAN antibody; CLCNKB antibody; hClC Kb antibody; hClCKb antibody; MGC24087 antibody; OTTHUMP00000011120 antibody; OTTHUMP00000011121 antibody; RP11 5P18.8 antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant Human Chloride channel protein ClC-Kb protein (538-687AA)
免疫原種屬：

Homo sapiens (Human)
標記方式：

Biotin
克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
產品提供形式：

Liquid
應用范圍：

ELISA
Protocols：

ELISA Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Voltage-gated chloride channel. Chloride channels have several functions including the regulation of cell volume; membrane potential stabilization, signal transduction and transepithelial transport. May be important in urinary concentrating mechanisms.
基因功能參考文獻：
1. Taking advantage of the largest number of functional results of CLCNKB mutations, we reveal the functionally important domains and severe mutational spots of the hClC-Kb channel and establish the genotype-phenotype association in classic Bartter's Syndrome. PMID: 28555925
2. Five patients had 1 or more mutations in CLCNKB, of whom 3 had homozygous mutations and 2 had single heterozygous mutations and only in CLCNKB had hypocalciuria. PMID: 26770037
3. Single loci of tag Single Nucleotide Polymorphisms of CLCNKA_B are not enough to increase the Essential Hypertension susceptibility, the combination of CLCNKA SNP, salt, marine products, meat, edible oil consumption is associated with elevated risk PMID: 25919862
4. results demonstrate that the carboxyl terminus of hClC-Kb is not part of the binding site for barttin, but functionally modifies the interplay with barttin. PMID: 26453302
5. These results demonstrate that mutations in a cluster of hydrophobic residues within transmembrane domain 1 affect barttin-CLC-K interaction and impair gating modification by the accessory subunit PMID: 26063802
6. we report here for the first time that ClC-Kb disease-causing mutations located around the selectivity filter can result in both reduced surface expression and hyperactivity in heterologous expression systems PMID: 24271511
7. Case Report: 2 mutations in the CLCNKB gene, leading to a molecular diagnosis of Bartter syndrome type III in case of sudden infant death. PMID: 25923035
8. study investigated the functional consequences of seven mutations; four mutants carried no current whereas others displayed a 30-60 percent reduction in conductance as compared with wild-type ClC-Kb PMID: 23703872
9. expands the association between CLCNKB and essential hypertension to a non-European ancestry population PMID: 22578033
10. This article presents the case of a patient with hypokalaemia caused by CLCNKB gene mutation hard to categorise as GS or BS type 3. PMID: 23345488
11. CLCNKB mutations are associated with Bartter syndrome. PMID: 21865213
12. novel missense variant of the CLCNKB gene in two patients with type III Bartter syndrome PMID: 21479528
13. there was no significant association between the SLC12A3 R904Q variant and the ClC-Kb-T481S variant and essential hypertension in Mongolian and Han populations in Inner Mongolia PMID: 21644212
14. four mutations in the CLCNKB gene, among patients suffering from bartter and Gitelman syndromes PMID: 21631963
15. Three novel CLCNKB mutations are identified associated with classic Bartter syndrome with a role in altering the functional properties of ClC-Kb channels. PMID: 19807735
16. DNA mutational analysis of CLCNKB in Bartter syndrome type 3. PMID: 11865110
17. presence of Gitelman and Bartter syndrome and CBS phenotypes, in a kindred with the CLCNKB R438H mutation. PMID: 12472765
18. CLCKB expression is demonstrated in stria vascularis, spiral ligament and limbal fibrocytes, interdental cells and satellite cells of spiral ganglion neurons of mice harboring enhanced green fluorescence protein gene driven by the human CLCKB promoter. PMID: 14502078
19. Genetic heterogeneity of ClC-Kb chloride channels correlates with functional heterogeneity, which assigns ClC-Kb to a set of genes potentially relevant for polygenic salt-sensitivity of blood pressure regulation. PMID: 14675050
20. The mutation ClC-Kb(T481S) of the renal epithelial Cl- channel ClC-Kb strongly activates ClC-Kb chloride channel function in vitro and may predispose to the development of essential hypertension in vivo. PMID: 15148291
21. There is no association with hypertension of CLCNKB polymorphism at a hypertension locus on chromosome 1p36. PMID: 16003175
22. confirms a weak genotype-phenotype correlation in patients with CLCNKB mutations and supports the founder effect of the A204T mutation in Spain PMID: 16391491
23. Identification of a novel mutation of the CLCNKB gene, DeltaL130 associated with Bartter syndrome. PMID: 16902263
24. Results identify large heterozygous deletion mutations in the CLCNKB gene in patients with type III Bartter syndrome. PMID: 17622951
25. roles of Thr418Ser polymorphism of the CLCNKB gene and Arg904Gln polymorphism in the TSC gene on essential hypertension need to be explored in other ethnic groups PMID: 17997379
26. In a large cohort of ante/neonatal Bartter syndrome, deafness, transient hyperkalaemia and severe hypokalaemic hypochloraemic alkalosis orientate molecular investigations to BSND, KCNJ1 and CLCNKB genes, respectively. PMID: 19096086
27. Threonine change to serine at position 481 in CLCNKB is associated with essential hypertension in males within the Ghanaian population. PMID: 19226700
顯示更多

收起更多
相關疾病：

Bartter syndrome 3 (BARTS3); Bartter syndrome 4B, neonatal, with sensorineural deafness (BARTS4B)
亞細胞定位：

Cell membrane; Multi-pass membrane protein.
蛋白家族：

Chloride channel (TC 2.A.49) family, CLCNKB subfamily
組織特異性：

Expressed predominantly in the kidney.
數據庫鏈接：

HGNC: 2027

OMIM: 602023

KEGG: hsa:1188

STRING: 9606.ENSP00000364831

UniGene: Hs.352243

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human